title: De novo generation of permanent neovascularized soft tissue appendages by platelet-derived growth factor.
abstract: Treatment of wounds with pharmacologic doses of the BB homodimeric form of recombinant PDGF (rPDGF-BB) induces the recruitment, activation, and proliferation of mesenchymal cells, resulting in the deposition of provisional, and subsequently collagen-containing extracellular matrix. In preliminary experiments with an in vitro growth chamber model in the rat consisting of a silicone shell containing a dissected femoral vascular bundle, we found that rPDGF-BB incorporated into a rapidly dissolving collagen type I film induces the generation of a marked, but transient amount of de novo tissue around the femoral vascular bundle. In the present studies, the new tissue generated around the femoral vascular bundle was wrapped with a full thickness syngeneic skin graft to determine if functional support of the graft would lead to sustained maintenance of the underlying generated tissue and create an epithelialized soft tissue appendage. The tissue generated after a single application of rPDGF-BB was skin grafted on the 10th day, exteriorized 20 d later, and observed for an additional month. This led to the formation of soft tissue appendages which demonstrated marked neovascularization, fibroblast migration and proliferation, and increased glycosaminoglycan, fibronectin, and collagen fibril deposition, now leading to preservation of the newly generated tissue. In contrast, minimal new tissue was generated in control-treated vascular bundles or bundles treated with inactive PDGF-BB, and grafting with skin failed to sustain the underlying tissue. Thus, rPDGF-BB coupled with skin grafting induced the formation of functional large soft tissue appendages which are potentially useful clinically to fill tissue defects or to serve as a cell delivery system for transfected genes.
authors.affiliation: Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.
authors.forename: R K
authors.initials: RK
authors.lastname: Khouri
authors.forename: S P
authors.initials: SP
authors.lastname: Hong
authors.forename: E G
authors.initials: EG
authors.lastname: Deune
authors.forename: J E
authors.initials: JE
authors.lastname: Tarpley
authors.forename: S Z
authors.initials: SZ
authors.lastname: Song
authors.forename: C M
authors.initials: CM
authors.lastname: Serdar
authors.forename: G F
authors.initials: GF
authors.lastname: Pierce
mesh_terms: D000818:Animals; D002455:Cell Division / Q000187:drug effects; D003094:Collagen / Q000378:metabolism; D005109:Extracellular Matrix / Q000502:physiology*; D015316:Genetic Therapy; D008297:Male; D009389:Neovascularization, Pathologic / Q000139:chemically induced*; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D011994:Recombinant Proteins / Q000494:pharmacology; D016038:Skin Transplantation
chemical_list: D010982:Platelet-Derived Growth Factor; D011994:Recombinant Proteins; D003094:Collagen